|Day Low/High||72.11 / 73.35|
|52 Wk Low/High||65.55 / 89.20|
Mylan pushed the blame for high EpiPen prices onto PBMs Thursday, causing share prices to dip. Analysts say investors were mislead.
Express Scripts (ESRX) stock was rallying Friday afternoon following a bullish note at Jefferies.
Wall Street will look to comments from Fed Chair Janet Yellen on interest rates; futures are higher; Carl Icahn recently discussed selling his stake in Herbalife, a report says.
Leerink analysts say Express Scripts (ESRX) stock may be lower today as a result of Mylan's (MYL) continued EpiPen controversy.
Earlier this month the two major pharmacy benefit managers, CVS Caremark CVS and Express Scripts ESRX released lists of drugs they will no longer cover in 2017.
Express Scripts (ESRX) is adding new drugs to its excluded list that won’t be covered by insurance.
Although Express Scripts shares have bounced off the bottom, it’s hard to see this stock climbing much further.
Joe Swedish said the healthcare insurer will fight a Department of Justice lawsuit that the agency filed to stop the $54.2 billion merger.
The company reports earnings at 8:30 a.m. on July 27.
A wave of key earnings report out overnight and this morning swept Wall Street away on Tuesday.
Stocks trade mixed Tuesday as a number of positive and negative earnings report keep traders active.
Stock futures are mixed as investors stay on the sidelines ahead of the kickoff to the Federal Reserve's July meeting.
The two have been embroiled in public sparring since before Anthem sued Express Scripts for $15 billion in damages in March.
Express Scripts (ESRX) reported 2016 second quarter earnings today that met analysts' expectations.
Express Scripts (ESRX) stock is falling in late afternoon trading Monday as the company is expected post second quarter results after today's market close.
Verizon strikes a $4.8 billion deal to acquire Yahoo!'s core operations, while Tesla and SolarCity are closer to a merger agreement.
The Federal Reserve will steal focus from another onslaught of earnings in the coming week as investors remain wary over the central bank's rate-hike timetable.
Shares of UnitedHealth are up nearly 22% year-to-date.
TheStreet highlights 3 stocks pushing the health care sector higher today.
Oppenheimer analysts say Cigna's stock looks attractive at present levels.
Glancy Prongay & Murray LLP ("GPM") reminds investors of the July 5, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the "Class") of investors who purchased Express...
Glancy Prongay & Murray LLP ("GPM") announces that a class action lawsuit has been filed on behalf of investors who purchased Express Scripts Holding Company ("Express Scripts" or the "Company") (NASDAQ: ESRX)...
Morgan Stanley cut its ratings on pharmacy benefit managers Express Scripts and CVS, saying that the PBM market is becoming more competitive.